Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.

This publication has 22 references indexed in Scilit:

• Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds
  Antimicrobial Agents and Chemotherapy, 1991
• Deoxycytidine kinase from human leukemic spleen: preparation and characterization of the homogeneous enzyme
  Biochemistry, 1988
• Action of the active metabolites of tiazofurin and ribavirin on purified IMP dehydrogenase
  Biochemistry, 1988
• The design, synthesis and antileukemic activity of 5-alkynyl-1-.BETA.-D-ribofuranosylimidazole-4-carboxamides.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1988
• Purification of IMP dehydrogenase from rat hepatoma 3924A
  Life Sciences, 1987
• Inhibition of inosinate dehydrogenase by metabolites of 2-β-D-ribofuranosylthiazole-4-car☐amide
  Biochemical and Biophysical Research Communications, 1982
• The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties
  Biochemical Pharmacology, 1982
• Mechanism and Specificity of Action of Ribavirin
  Antimicrobial Agents and Chemotherapy, 1979
• Inhibition of influenza RNA synthesis by virazole (ribavirin)
  Archiv für die gesamte Virusforschung, 1976
• Studies of Phosphorylation. III. Selective Phosphorylation of Unprotected Nucleosides
  Bulletin of the Chemical Society of Japan, 1969